--- title: "箭头制药 (ARWR.US) — 财务报表" type: "Symbol" locale: "zh-CN" url: "https://longbridge.com/zh-CN/quote/ARWR.US/norm.md" symbol: "ARWR.US" name: "箭头制药" parent: "https://longbridge.com/zh-CN/quote/ARWR.US.md" datetime: "2026-05-19T20:37:12.103Z" locales: - [en](https://longbridge.com/en/quote/ARWR.US/norm.md) - [zh-CN](https://longbridge.com/zh-CN/quote/ARWR.US/norm.md) - [zh-HK](https://longbridge.com/zh-HK/quote/ARWR.US/norm.md) --- # 箭头制药 (ARWR.US) — 财务报表 ## 利润表 (USD) | 指标 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | | --- | --- | --- | --- | --- | --- | | 每股收益 | -0.9320 | 0.2200 | -0.1741 | -1.26 | 2.75 | | ROE | -89.81% | 23.83% | -19.22% | -116.28% | 402.71% | | 营业收入 | 73.74M | 264.03M | 256.47M | 27.77M | 542.71M | | 净利润 | -132.73M | 30.81M | -23.75M | -175.24M | 370.44M | | 营业利润 | -141.26M | 40.81M | 44.11M | -165.55M | 381.20M | | 毛利率 | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | | 净利率 | -180.01% | 11.67% | -9.26% | -631.11% | 68.26% | | 利润含金量 | -167.29% | 302.71% | 215.25% | - | 82.86% | ## 资产负债表 (USD) | 指标 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | | --- | --- | --- | --- | --- | --- | | 资产与负债 | 2.27B | 1.60B | 1.39B | 1.38B | 1.57B | | 权益乘数 | 3.79 | 2.85 | 2.75 | 2.66 | 2.30 | | 每股净资产 | 4.37 | 4.14 | 3.43 | 3.78 | 4.95 | | 资产周转率 | 0.3238 | 0.8335 | 0.6570 | 0.5061 | 0.4312 | | 现金及短投 | 1.78B | 914.71M | 917.47M | 898.17M | 1.10B | | 存货与应收 | - | - | - | - | - | | 长期投资 | 417.62M | 421.94M | 426.41M | 425.05M | 429.25M | | 净债务 | -398.40M | -216.55M | -173.49M | -177.79M | -354.80M | ## 现金流量表 (USD) | 指标 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | | --- | --- | --- | --- | --- | --- | | 经营现金流 | 84.44M | 13.48M | 20.49M | -154.72M | 460.05M | | 投资现金流 | -894.28M | -23.74M | 72.62M | 141.39M | -420.21M | | 融资现金流 | 795.72M | -14.75M | 3.67M | -42.68M | 92.38M | | 自由现金流 | 81.90M | -25.79M | 58.61M | -103.75M | 298.04M | | 现金流充裕率 | 414.11% | 19.59% | 273.61% | -295.47% | 293.17% | | 举债与偿债 | 700.00M | - | 3.16M | 7.10M | - | | 资本支出 | -2.56M | -2.15M | -7.49M | -2.36M | -5.30M |